23:58 IST
BSE
Annual General Meeting
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Ltd
- Share price
- ₹25.55
- Market cap
- ₹12.96 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.8×Sector 47.3×
- Promoter holding
- 27.82%+0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Outcome 4Board Meeting Date 4Annual General Meeting 4Promoter Buying 3Other Announcement 3Financial Results 3Debt & Borrowing 1Capacity Expansion 1Annual Report 1Adverse Business Impact 1
Time
4 announcements with these filters
17:45 IST
BSE
Annual General Meeting
Beryl Drugs Annual General Meeting
Beryl Drugs Limited concluded its Extra-Ordinary General Meeting on May 11, 2026. Shareholders approved director appointments and material related party transactions through remote e-voting and polling.
17:19 IST
BSE
Annual General Meeting
Beryl Drugs Annual General Meeting
Beryl Drugs Limited shareholders approved all resolutions at the May 11 EGM with 100% favor. Appointments and related party transactions were passed unanimously by the company.
11:43 IST
BSE
Annual General Meeting
Beryl Drugs Annual General Meeting
Beryl Drugs Limited shareholders approved new director appointments and material related party transactions during the EGM. The meeting concluded successfully with all requisite majorities.